ReviewOncoTargets and therapy2016
Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors.
Elias A Kotteas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it